Kianoush Motesharei - 24 May 2021 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Officer
Signature
/s/ Sam Backenroth, as attorney-in-fact for Kianoush Motesharei
Issuer symbol
NBSE
Transactions as of
24 May 2021
Net transactions value
$0
Form type
4
Filing time
25 May 2021, 16:12:32 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Employee stock option (right to buy) Award $0 +250,000 $0.000000 250,000 24 May 2021 Common stock 250,000 $5.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the total shares shall vest on the first anniversary of the effective date of employment, and 1/36th of the remaining shares shall vest on a monthly basis starting on the first anniversary of the effective date of employment; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive.

Remarks:

Chief Business and Strategy Officer. The power of attorney under which this form was signed is on file with the Commission.